公司资料
Sanara MedTech 股价、新闻与催化剂
- 股票代码:
- SMTI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
34.00 USD (-0.44%)
收盘价
最后更新: 2026年8月17日
195M USD
市值
股价为何变动
As of Aug 17, 2026, SMTI closed down 0.44% at $34.00. No new same-company headline was identified in the current news window.
公司概览
Surgical Wound and Tissue Repair
Sanara MedTech develops and commercializes products intended to improve surgical healing and reduce complications and healthcare costs.
Soft-Tissue Repair Portfolio
The company’s products address wound cleansing, infection management, extracellular matrix support, and tissue repair across surgical specialties.
Procedure-Based Commercial Model
Sanara sells through hospital and surgeon relationships, with revenue driven by procedure volumes, product adoption, and expansion of its direct commercial organization.
Technology Acquisition Strategy
The company supplements internal development with licensed and acquired technologies that can be distributed through its existing surgical channel.
未来催化剂
- Sanara MedTech’s catalysts are wound-care and surgical-product sales, along with continued execution in specialty care. It is a steady operating story, so the market will focus on adoption and margin discipline.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。